Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript

DVAX earnings call for the period ending December 31, 2023.

DVAX : 11.72 (+0.34%)
Why Vera Therapeutics Stock Soared by 22% This Week

Executive changes and a bullish analyst take combined to boost sentiment on the company.

AMGN : 278.39 (+0.37%)
DVAX : 11.72 (+0.34%)
VERA : 43.50 (+2.79%)
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript

DVAX earnings call for the period ending September 30, 2023.

DVAX : 11.72 (+0.34%)
Dynavax Technologies: Q3 Earnings Snapshot

Dynavax Technologies: Q3 Earnings Snapshot

DVAX : 11.72 (+0.34%)
Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.72 (+0.34%)
Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.72 (+0.34%)
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript

DVAX earnings call for the period ending June 30, 2023.

DVAX : 11.72 (+0.34%)
Dynavax Technologies: Q2 Earnings Snapshot

Dynavax Technologies: Q2 Earnings Snapshot

DVAX : 11.72 (+0.34%)
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.72 (+0.34%)
Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.72 (+0.34%)

Barchart Exclusives

3 Energy Dividend Stocks to Invest in Oil's 'Higher for Longer' Scenario
Discover how Schlumberger, Baker Hughes, and Halliburton are leveraging their robust financial health and strategic initiatives to thrive in a market where oil prices are expected to remain elevated, in our latest deep dive into the energy sector's top performers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar